Department of Neurosurgery, Charles University Medical Faculty and Faculty Hospital, Hradec Králové, Czech Republic.
Department of Neuroregeneration, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czech Republic.
J Thromb Thrombolysis. 2021 Nov;52(4):1215-1219. doi: 10.1007/s11239-021-02462-y. Epub 2021 May 6.
Spontaneous spinal epidural hematoma (SSEH) is a very rare clinical entity with potential diagnostic difficulties and which can result in severe neurological deficit. The etiology of this rare condition is largely not known, but with potential predisposition in patients on anticoagulation medication. This includes the novel anticoagulants with direct inhibition of the factor Xa mechanism (DOACs). These medications are supposed to have more predictable pharmacokinetics with fewer severe haemorrhagic adverse events in comparison with standard warfarin therapy. However, in the last few years, an increasing number of case reports have been published of haemorrhage into the central nervous system. We present a case of non-traumatic spinal epidural hematoma in the lumbar region in a patient on chronic apixaban therapy. To the best of our knowledge, it is the first described SSEH in the lumbar region associated with apixaban therapy.
自发性脊柱硬膜外血肿(SSEH)是一种非常罕见的临床病症,具有潜在的诊断困难,可能导致严重的神经功能缺损。这种罕见病症的病因在很大程度上尚不清楚,但接受抗凝药物治疗的患者存在潜在的易患因素。这些抗凝药物包括直接抑制因子 Xa 机制的新型抗凝剂(DOACs)。与标准华法林治疗相比,这些药物的药代动力学更具可预测性,严重出血不良事件更少。然而,在过去几年中,越来越多的病例报告显示中枢神经系统出血。我们报告了一例在接受慢性阿哌沙班治疗的患者中发生的非创伤性腰椎脊柱硬膜外血肿。据我们所知,这是首例与阿哌沙班治疗相关的腰椎 SSEH 病例。